NATALIE BREEDEN: Open Payments
NPI 1063140895 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$233 in 11 payments from 7 companies in 2025. Trend: 2023 $597 · 2024 $320 · 2025 $233
Food & beverage: $233
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $60 |
| Pacira Pharmaceuticals Incorporated | 2 | $59 |
| Smith+Nephew, Inc. | 2 | $33 |
| Bioventus LLC | 1 | $23 |
| SI-BONE, INC. | 1 | $23 |
| Solventum Corporation | 1 | $20 |
| Heron Therapeutics, Inc. | 1 | $15 |
Products named: JOURNAVX, Exparel, STRAVIX, DUROLANE, PREVENA, ZYNRELEF.
Industry payments across MA — which companies pay providers there.
